The study aims to evaluate the safety and efficacy of modafinil (200 mg/day) over 10 weeks
plus a tailored cognitive behavioural therapy program in the treatment of methamphetamine
dependence.
Phase:
Phase 2
Details
Lead Sponsor:
The University of New South Wales
Collaborators:
Australian Government Department of Health and Ageing Kirketon Road Centre, Sydney Hospital St Vincent's Hospital, Sydney